Clinical trial
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant…
NCT00107198 · Children's Oncology Group, Other · Active, not recruiting
Key facts
| NCT number | NCT00107198 |
|---|---|
| Title | Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease |
| Official title | Treatment of Children With Newly-Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease (LPHD) |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ann Arbor Stage I Childhood Hodgkin Lymphoma, Ann Arbor Stage II Childhood Hodgkin Lymphoma, Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Conventional Surgery, Cyclophosphamide, Doxorubicin Hydrochloride, Prednisone, Radiation Therapy, Vincristine Sulfate |
| Enrollment | 188 |
| Start date | Jan 2, 2006 |
| Primary completion | Oct 6, 2015 |
| Completion | Dec 31, 2030 |
| First posted | Apr 6, 2005 |
| Last update posted | Sep 18, 2025 |
| Countries | Australia, Canada, Israel, New Zealand, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: